Literature DB >> 33355879

Portable fixed dynamometry: towards remote muscle strength measurements in patients with motor neuron disease.

Jaap N E Bakers1,2,3, Leonard H van den Berg1, Toju G Ajeks1, Maxine J Holleman1, Jill Verhoeven1, Anita Beelen2,3, Johanna M A Visser-Meily2,3, Ruben P A van Eijk4,5.   

Abstract

BACKGROUND: We aimed to determine (1) the test-retest reliability of a newly developed portable fixed dynamometer (PFD) as compared to the hand-held dynamometer (HHD) in patients with motor neuron disease (MND) and (2) the PFD's ability to reduce possible examiner-induced ceiling effects.
METHODS: Test-retest reliability of isometric muscle strength of the quadriceps was measured in patients with MND and non-neurological controls using the HHD and PFD. Reliability was estimated by the intraclass correlation coefficient (ICC) and standard error of measurement (SEM) using linear mixed effects models, and the Bland-Altman method of agreement.
RESULTS: In total, 45 patients with MND and 43 healthy controls were enrolled in this study. The ICC of the PFD was excellent and similar in both patients and controls (ICC Patients 99.5% vs. ICC Controls 98.6%) with a SEM of 6.2%. A strong examiner-induced ceiling effect in HHD was found when the participant's strength exceeded that of examiner. Employing the PFD increased the range of muscle strength measurements across individuals nearly twofold from 414 to 783 N.
CONCLUSIONS: Portable fixed dynamometry may significantly reduce examiner-induced ceiling effects, optimize the standardization of muscle strength testing, and maximize reliability. Ultimately, PFD may improve the delivery of care due to its potential for unsupervised, home-based assessments and reduce the burden to the patient of participating in clinical trials for MND or other neuromuscular diseases.

Entities:  

Keywords:  Fixed dynamometry; Motor neuron disease; Muscle strength; Reliability study; Remote monitoring

Year:  2020        PMID: 33355879     DOI: 10.1007/s00415-020-10366-9

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  39 in total

1.  Enhancing the examiner's resisting force improves the validity of manual muscle strength measurements: application to knee extensors and flexors.

Authors:  Tung-Wu Lu; Hui-Lien Chien; Ling-Ying Chang; Horng-Chaung Hsu
Journal:  J Strength Cond Res       Date:  2012-09       Impact factor: 3.775

2.  Validation of a new strength measurement device for amyotrophic lateral sclerosis clinical trials.

Authors:  Patricia L Andres; Linda M Skerry; Theodore L Munsat; Brenda J Thornell; Jackie Szymonifka; David A Schoenfeld; Merit E Cudkowicz
Journal:  Muscle Nerve       Date:  2012-01       Impact factor: 3.217

3.  Fixed Handheld Dynamometry Provides Reliable and Valid Values for Quadriceps Isometric Strength in People With Chronic Obstructive Pulmonary Disease: A Multicenter Study.

Authors:  Kim-Ly Bui; Sunita Mathur; Gail Dechman; François Maltais; Pat Camp; Didier Saey
Journal:  Phys Ther       Date:  2019-09-01

4.  Enhancing the examiner's resisting force improves the reliability of manual muscle strength measurements: comparison of a new device with hand-held dynamometry.

Authors:  Tung-Wu Lu; Horng-Chaung Hsu; Ling-Ying Chang; Hao-Ling Chen
Journal:  J Rehabil Med       Date:  2007-11       Impact factor: 2.912

Review 5.  Measures and markers in amyotrophic lateral sclerosis.

Authors:  Merit Cudkowicz; Muhammad Qureshi; Jeremy Shefner
Journal:  NeuroRx       Date:  2004-04

6.  Hand-held Dynamometer Measurements: Tester Strength Makes a Difference.

Authors:  J B Wikholm; R W Bohannon
Journal:  J Orthop Sports Phys Ther       Date:  1991       Impact factor: 4.751

Review 7.  The influence of subject and test design on dynamometric measurements of extremity muscles.

Authors:  J L Keating; T A Matyas
Journal:  Phys Ther       Date:  1996-08

Review 8.  Clinical Measures of Disease Progression in Amyotrophic Lateral Sclerosis.

Authors:  Seward B Rutkove
Journal:  Neurotherapeutics       Date:  2015-04       Impact factor: 7.620

9.  Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial.

Authors:  Vincent Meininger; Angela Genge; Leonard H van den Berg; Wim Robberecht; Albert Ludolph; Adriano Chio; Seung H Kim; P Nigel Leigh; Matthew C Kiernan; Jeremy M Shefner; Claude Desnuelle; Karen E Morrison; Susanne Petri; Diane Boswell; Jane Temple; Rajat Mohindra; Matt Davies; Jonathan Bullman; Paul Rees; Arseniy Lavrov
Journal:  Lancet Neurol       Date:  2017-01-28       Impact factor: 44.182

10.  Safety and efficacy of ceftriaxone for amyotrophic lateral sclerosis: a multi-stage, randomised, double-blind, placebo-controlled trial.

Authors:  Merit E Cudkowicz; Sarah Titus; Marianne Kearney; Hong Yu; Alexander Sherman; David Schoenfeld; Douglas Hayden; Amy Shui; Benjamin Brooks; Robin Conwit; Donna Felsenstein; David J Greenblatt; Myles Keroack; John T Kissel; Robert Miller; Jeffrey Rosenfeld; Jeffrey D Rothstein; Ericka Simpson; Nina Tolkoff-Rubin; Lorne Zinman; Jeremy M Shefner
Journal:  Lancet Neurol       Date:  2014-10-05       Impact factor: 44.182

View more
  4 in total

Review 1.  Considerations for Amyotrophic Lateral Sclerosis (ALS) Clinical Trial Design.

Authors:  Christina N Fournier
Journal:  Neurotherapeutics       Date:  2022-07-11       Impact factor: 6.088

2.  Patient perspectives on digital healthcare technology in care and clinical trials for motor neuron disease: an international survey.

Authors:  Barbara Johnson; Cory Holdom; Chris McDermott; Ruben P A van Eijk; Jochem Helleman; Esther Hobson; Deirdre Murray; Frederik J Steyn; Shyuan T Ngo; Anjali Henders; Madhura B Lokeshappa; Johanna M A Visser-Meily; Leonard H van den Berg; Orla Hardiman; Anita Beelen
Journal:  J Neurol       Date:  2022-07-18       Impact factor: 6.682

Review 3.  A systematic review of digital technology to evaluate motor function and disease progression in motor neuron disease.

Authors:  Emily Beswick; Thomas Fawcett; Zack Hassan; Deborah Forbes; Rachel Dakin; Judith Newton; Sharon Abrahams; Alan Carson; Siddharthan Chandran; David Perry; Suvankar Pal
Journal:  J Neurol       Date:  2022-08-09       Impact factor: 6.682

Review 4.  Leap Motion Controller Video Game-Based Therapy for Upper Extremity Motor Recovery in Patients with Central Nervous System Diseases. A Systematic Review with Meta-Analysis.

Authors:  Irene Cortés-Pérez; Noelia Zagalaz-Anula; Desirée Montoro-Cárdenas; Rafael Lomas-Vega; Esteban Obrero-Gaitán; María Catalina Osuna-Pérez
Journal:  Sensors (Basel)       Date:  2021-03-15       Impact factor: 3.576

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.